TrialPloS one2024

Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines.

Thomas Wilkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.